<DOC>
	<DOC>NCT01655108</DOC>
	<brief_summary>This study aims to investigate the effectiveness and safety of mesotherapy for the treatment of female pattern alopecia. - Sixty female subjects between 18 and 65 years diagnosed with female pattern hair loss will undergo mesotherapy sessions weekly for ten weeks. - One group will receive 0.5%/2ml minoxidil application and a control group will receive application of placebo (saline 0.9%). - Biopsy of the scalp, trichogram and trichoscopy (Fotofinder) will be performed before and 08 weeks after treatment as a method objective evaluation of the response</brief_summary>
	<brief_title>Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients</brief_title>
	<detailed_description>This is a trial that aims to analyze the efficacy and safety of mesotherapy with minoxidil 0,5% versus placebo for androgenetic alopecia in female patients. The patients and the investigators who analyzes complementary exams are blind. - Clinical criteria, photo, 4mm biopsia, trichogram and trichoscopy are perfomed before patients are randomized into two arms : 1. Group 1 (Placebo): 30 patients who will have intradermal injections in the scalp of saline 0.9% 2. Group 2 (Active Drug): 30 patients who will receive intradermal injections in the scalp with minoxidil 0.5%/2ml Eight weeks after the last session patients will be recruited for repeat the exams and perform a self-assessment of both the effect on hair growth and the effect on hair loss.</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>Women from 18 to 65 years old Androgenetic Alopecia (female pattern hair loss) patients with alopecia areata or cicatricial alopecia pregnancy and breastfeeding have undergone any specific treatment in the last 06 months use of drugs with antiandrogenic properties patients with signs or symptoms of hyperandrogynism</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Androgenetic Alopecia</keyword>
	<keyword>Mesotherapy</keyword>
	<keyword>Minoxidil</keyword>
	<keyword>Trichogram</keyword>
</DOC>